• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Parasitic worms
      • Mycetoma
      • Dengue
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Evidence for impact
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi West and Central Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • Our story
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Parasitic worms
      • Mycetoma
      • Dengue
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Evidence for impact
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi West and Central Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • Our story
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Page 4 > News & stories

News

Page 4 > News & stories

News

filters

Type & Disease
Topic
Location
Date Range
Type & Disease

By Type

news type

By Disease

diseases

Topic

By Topic

topic type

Location

By Location

location-news

Date Range

By Year

date range filter – slider
1999 — 2026

Results

No results found. Please try using different filter option(s).

Publications
6 Nov 2026

Extreme heat and climate-sensitive infectious diseases

News
2 Nov 2026

Project to develop dengue treatment pre-selected by the Global Coalition for Local and Regional Production, Innovation, and Equitable Access

close up of a scientist holding tools they are wearing blue gloves
Press releases
29 Oct 2026

DNDi welcomes GHIT Fund’s support for innovative approaches to improve success in Chagas disease drug discovery with Nagasaki University, the University of Dundee, and Eisai 

Scientific articles
27 Oct 2026

Strengthening health systems and clinical development capacities through effective partnerships: a case study of DNDi’s collaboration with the Leishmaniasis Research and Treatment Center in Ethiopia (2003–2022)

Frontiers in Tropical Diseases
Press releases
27 Oct 2026

Kenya becomes first African country to join the Dengue Alliance

Scientific articles
26 Oct 2026

Efficacy and safety of oxfendazole in adults with Trichuris spp. infection in Pemba Island, Tanzania: a double-blind, phase 2a, randomised controlled trial

eClinicalMedicine
Scientific articles
22 Oct 2026

Deconvoluting the mode of action of antileishmanial aminopyrazoles through chemical mutagenesis

Nature communications
Scientific articles
10 Oct 2026

Rethinking Clinical Trial Design to Accelerate Therapeutics for Arboviral Epidemics

Open Forum Infectious Diseases
News
9 Oct 2026

DNDi 2026 Projects of the Year recognize teams and partners for their work to advance an open-science antiviral for future coronavirus pandemics and a single-dose treatment for sleeping sickness

Scientific articles
9 Oct 2026

A Perspective on Biomarkers, Candidates for Surrogate End Points to Accelerate Successful Development of New Antiparasitic Agents for the Treatment of Chronic Chagas Disease

ACS Infectious Diseases
Press releases
6 Oct 2026

Ghana’s KNUST and DNDi partner to accelerate drug discovery for neglected diseases in Africa

Scientific articles
5 Oct 2026

Winning the endgame against sleeping sickness: Efficacy profiling of acoziborole against African trypanosomes with the focus on Trypanosoma brucei rhodesiense

PLoS Neglected Tropical Diseases
Statements
25 Sep 2026

DNDi intervention at the UN High-Level Meeting on Pandemic Prevention, Preparedness, and Response at the 81st UN General Assembly

El Pais logo
In the media
24 Sep 2026

De Etiopía a Lleida: la desigualdad mata tanto como los virus durante una pandemia

El País
Scientific articles
22 Sep 2026

Efficacy and safety of alternative benznidazole and nifurtimox regimens for adults with chronic Trypanosoma cruzi infection (TESEO): an open-label, randomised, non-inferiority phase 2b trial

The Lancet Infectious Diseases
Scientific articles
19 Sep 2026

Thermotherapy compared with intralesional sodium stibogluconate for Leishmania aethiopica cutaneous Leishmaniasis in Ethiopia: A phase II randomized controlled trial

BMC Medicine
loading
Loading...
News
News Translations
News
30 Jan 2025

Science and collaboration can end the neglect – World NTD Day 2025

Yves Champey in 2013 at DNDi's 10 Year Anniversary event in Paris
News
19 Dec 2024

Message on the passing of Dr Yves Champey from DNDi Executive Director Dr Luis Pizarro

News
17 Dec 2024

DNDi 2024 in Review

Computer screen
News
10 Oct 2024

Nobel prize for chemistry awarded to Demis Hassabis and John Jumper for AlphaFold, an AI model used by DNDi for neglected diseases

News
4 Oct 2024

DNDi 2024 Projects of the Year recognize contributions of DNDi teams and partners working to deliver medical innovations for people affected by leishmaniasis and sleeping sickness

Health worker looking into a microscope
News
4 Oct 2024

DNDi media fellowship for Eastern African health journalists

Alwyn Mwinga
News
6 Sep 2024

Message on the passing of Dr Alwyn Mwinga from DNDi Executive Director Dr Luis Pizarro

Doctor and patient
News
2 Apr 2024

Ravidasvir journey

Lab activities
News
1 Apr 2024

Pandemic preparedness: DNDi and THSTI receive financial support from Novo Nordisk Foundation to develop broad-spectrum, host-directed antivirals

Doctor cares for child
News
28 Mar 2024

2023 R&D portfolio in review: Dengue

Doctor examining eyes
News
28 Mar 2024

2023 R&D portfolio in review: Filaria – river blindness

Woman holding baby and bucket
News
28 Mar 2024

2023 R&D portfolio in review: Sleeping sickness

Woman and man sitting
News
28 Mar 2024

2023 R&D portfolio in review: Hepatitis C

Doctor standing outside hospital
News
28 Mar 2024

2023 R&D portfolio in review: HIV

Man sitting in front of wall
News
28 Mar 2024

2023 R&D portfolio in review: Leishmaniasis

News
28 Mar 2024

2023 R&D portfolio in review: Chagas

1 2 … 16 ›

Stay connected

Get our latest news, personal stories, research articles, and job opportunities. 

Linkedin-in Instagram Youtube Tiktok Facebook-f
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films, and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International license